| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5686920 | The Journal of Urology | 2017 | 28 Pages |
Abstract
Poor overall survival following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma with tumor thrombus is associated with inferior vena cava thrombus above the diaphragm, poor risk group, systemic symptoms or sarcomatoid dedifferentiation. Patients with expected poor overall survival should be considered for preoperative systemic therapy clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
E. Jason Abel, Philippe E. Spiess, Vitaly Margulis, Viraj A. Master, Michael Mann, Kamran Zargar-Shoshtari, Leonardo D. Borregales, Wade J. Sexton, Datta Patil, Surena F. Matin, Christopher G. Wood, Jose A. Karam,